UPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against TransEnterix, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / July 28, 2016 / Khang & Khang LLP (the “Firm”) announces that a class action lawsuit was filed against TransEnterix, Inc. (“TransEnterix” or the “Company”) (NYSE MKT: TRXC). Investors who purchased or otherwise acquired shares between February 10, 2016 and May 10, 2016 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the August
1, 2016 lead plaintiff motion deadline.

If you purchased shares of TransEnterix during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that, throughout the Class Period, TransEnterix made false and misleading statements and/or failed to disclose that: there were deficiencies within the Company’s 510(k) submission regarding the SurgiBot that undermined the likelihood that the SurgiBot would receive clearance from the Food and Drug Administration, which would leave TransEnterix unable to commercialize the SurgiBot in 2016, and would impair the Company’s ability to obtain approval for and commercialize its other robotic surgery platform in the United States.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 442958